🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients with schizophrenia have problems in thinking, known as cognitive d...
Status
Completed
Location
University of California Los Angeles School of Medicine
Start Date
2005-09
Trial ID
NCT00423943
Despite years of active research, there are still no approved medications f...
Status
Completed
Location
University of Pennsylvania
Start Date
2004-07
Trial ID
NCT00129285
Treatments Being Tested
The purpose of this research study is to study the effectiveness, tolerabil...
Status
Completed
Location
Lindner Center of HOPE
Start Date
2009-11
Trial ID
NCT01010789
Treatments Being Tested
The purpose of this study is to assess the potential interactions between i...
Status
Unknown
Location
U of CA, San Francisco
Start Date
2005-03
Trial ID
NCT00265278
Treatments Being Tested
The primary objective of the study is to evaluate whether armodafinil at a ...
Status
Completed
Location
Jasper Summit Research, LLC
Start Date
2007-10
Trial ID
NCT00518986
Treatments Being Tested
The study aims to evaluate the safety and efficacy of modafinil (200 mg/day...
Status
Unknown
Location
Alcohol and Drug Services, St Vincent's Hospital
Start Date
2006-07
Trial ID
NCT00123370
Treatments Being Tested
This pilot study is an eight-week, randomized, double-blind, placebo-contro...
Status
Completed
Location
Freedom Trail Clinic
Start Date
2003-09
Trial ID
NCT00573417
This is a four-arm, randomized, controlled, clinical trial examining the ef...
Status
Completed
Location
University of Rochester James P. Wilmot Cancer Center
Start Date
2008-02
Trial ID
NCT01091974
Treatments Being Tested
The purpose of this pilot study is to evaluate whether modafinil is helpful...
Status
Completed
Location
New York State Psychiatric Institute-Columbia University
Start Date
2006-06
Trial ID
NCT00614926
This Phase 2 study is a 8-site, double-blind, randomised, placebo-controlle...
Status
Completed
Location
RespiSom
Start Date
2016-09
Trial ID
NCT02821715
Treatments Being Tested